Caoimhghín Ó Caoláin
Question:752. Deputy Caoimhghín Ó Caoláin asked the Minister for Health his views on the suggested relationship between breast cancer screening and incidence (details supplied). [4060/14]
View answerTuesday, 28 January 2014
Questions (752)
Written answers
BreastCheck, the National Breast Screening Programme, is carried out in Ireland in line with EU Guidelines that are based on recommendation from the International Agency for Research on Cancer which is a WHO agency. BreastCheck's approach, involving a population-based ongoing call and recall system with outcomes being reviewed by two consultant radiologists, provides a quality service in Ireland. It has a clear commitment to providing transparent information to women invited for screening - with the benefits and limitations of screening clearly explained. Digital mammography is utilised as this is the most advanced method available, giving enhanced image quality and significant reductions in the radiation dose associated with screening examinations. While not all breast cancers can be found by mammogram, breast screening helps to identify cancers at an early stage when its easier to treat the patient, leading to less extensive surgical treatment, a better chance of a good recovery and improved quality of life.
Breast cancer survival in Ireland has improved significantly in recent years due to a combined approach of screening, symptomatic detection and improved treatment. Breast cancer 5 year survival is now estimated at 81.8% for people diagnosed between 2003-2007, up from 76.8% for people diagnosed between 1998-2002. Meanwhile, the latest projections from the National Cancer Registry indicate that the incidence of cancer, including breast cancer, in Ireland is expected to rise in the period up to 2040. They attribute this to demographic changes such as population size and an aging population.